ASCO 2018 | Moving forwards with CAR T-cells in myeloma

Noopur Raje

CAR T-cells are an exciting therapeutic avenue for multiple myeloma (MM). Here, Noopur Raje, MD, of Massachusetts General Hospital Cancer Center, Boston, MA, discusses exciting future routes for this therapy and gives an expert insight into the key focuses of this research. This video was recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting in Chicago, IL.

Share this video